Clinical trials of convalescent plasma therapy for coronavirus disease 2019 (COVID‐19) are extensive, but the relationship between antibody titers, infused volume of plasma and virus clearance in patients remains unknown.… Click to show full abstract
Clinical trials of convalescent plasma therapy for coronavirus disease 2019 (COVID‐19) are extensive, but the relationship between antibody titers, infused volume of plasma and virus clearance in patients remains unknown. This study proposed a possible estimating equation for clinical use of high antibody titer convalescent plasma.
               
Click one of the above tabs to view related content.